Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Ep 3 Efficacy and Safety of Apremilast Monotherapy for Moderate to Severe Psoriasis: Retrospective Study

Ep 3 Efficacy and Safety of Apremilast Monotherapy for Moderate to Severe Psoriasis: Retrospective Study

FromJCMS: Author Interviews & Editor's Choice with Dr Kirk Barber (Listen and earn CME credit)


Ep 3 Efficacy and Safety of Apremilast Monotherapy for Moderate to Severe Psoriasis: Retrospective Study

FromJCMS: Author Interviews & Editor's Choice with Dr Kirk Barber (Listen and earn CME credit)

ratings:
Length:
23 minutes
Released:
Aug 13, 2018
Format:
Podcast episode

Description

Dr Kirk Barber speaks with Dr Jensen Yeung a dermatologist at the University of Toronto and the medical director of PERC, the Phototherapy Education and Research Centre at Women’s College Hospital in Toronto about the study he co-authored that examines the efficacy and safety of Apremilast monotherapy for moderate to severe Psoriasis. He also offers valuable insights into his use clinical use of apremilast outlining the risks and benefits from the perspective of a clinician.Theme music: "Start of the Day" by Lee Rosevere licensed under a Creative Commons Attribution License
Released:
Aug 13, 2018
Format:
Podcast episode

Titles in the series (63)

Engaging conversations with authors of articles from the Journal of Cutaneous Medicine and Surgery. JCMS is the peer-reviewed journal of the Canadian Dermatology Association.